, Tracking Stock Market Picks
Enter Symbol:
Keryx Biopharmaceuticals, Inc. (KERX) [hlAlert]

up 884.12 %

Keryx Biopharmaceuticals, Inc. (KERX) rated Accumulate by Punk Ziegel & Co

Posted on: Tuesday,  Mar 11, 2008  10:25 AM ET by Punk Ziegel & Co

Punk Ziegel & Co rated Accumulate Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) on 03/11/2008, when the stock price was $0.63.
Since then, Keryx Biopharmaceuticals, Inc. has gained 884.13% as of 01/12/2016's recent price of $6.20.
If you would have followed this Punk Ziegel & Co's recommendation on KERX, you would have gained 884.12% of your investment in 2863 days.

Keryx Biophamaceutical, Inc. uses data discovered through the mapping of the human genome to generate drug candidates that target the regulation of protein kinases. Protein kinases play a key role in the way cells communicate.

Our Research Department takes a fresh, critical approach to analyzing primary sources and developing proprietary research. Many individuals, institutions, portfolio managers and hedge fund managers, on all levels, have been neglected by brokerage firms ignoring the demands for unbiased research. Ladenburg Thalmann provides a superior branded in-depth research product geared only to action-oriented investment ideas. Ladenburg Thalmann’s proprietary equity research tries to uncover crucial information before the rest of the Street. Our analysts concentrate on uncovered and under-covered stocks and have a small to mid-cap focus. We will not shy away from large cap names as long as we can bring value to our clients through timely, differentiated ideas.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/11/2008 10:25 AM Buy
as of 12/24/2008
1 Week up  27.77 %
1 Month up  64.28 %
3 Months   
1 YTD up  4.54 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy